Onconetix Inc
For the period ended Jun 30, 2024. Filed Aug 29, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 29, 2024
ONCO$3.47-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
| Three Months Ended · Three Months Ended · Six Months Ended · Six Months Ended | ||||||
|---|---|---|---|---|---|---|
| June 30, 2024 · June 30, 2023 · June 30, 2024 · June 30, 2023 | ||||||
| Revenue | $704,848 | $ | - | $1,405,281 | $ | - |
| Cost of revenue | 604,132 | - | 1,115,565 | - | ||
| Gross profit | 100,716 | - | 289,716 | - | ||
| Operating expenses | ||||||
| Selling, general and administrative | 2,221,275 | 2,302,747 | 5,957,725 | 4,068,770 | ||
| Research and development | (3,680) | 846,853 | 45,284 | 1,929,089 | ||
| Impairment of ENTADFI assets | 1,237,140 | - | 3,530,716 | - | ||
| Impairment of goodwill | 10,261,000 | - | 15,453,000 | - | ||
| Impairment of deposit on asset purchase agreement | - | 3,500,000 | - | 3,500,000 | ||
| Total operating expenses | 13,715,735 | 6,649,600 | 24,986,725 | 9,497,859 | ||
| Loss from operations | (13,615,019) | (6,649,600) | (24,697,009) | (9,497,859) | ||
| Other (expense) income | ||||||
| Interest expense - related party | (156,169) | - | (380,943) | - | ||
| Interest expense | (205,146) | (213,996) | (393,429) | (213,996) | ||
| Change in fair value of subscription agreement liability – related party | (248,000) | - | (21,600) | - | ||
| Change in fair value of contingent warrant liability | - | (1,674) | - | (59) | ||
| Other - net | (31,602) | - | (3,094) | - | ||
| Total other expense | (640,917) | (215,670) | (799,066) | (214,055) | ||
| Loss before income taxes | (14,255,936) | (6,865,270) | (25,496,075) | (9,711,914) | ||
| Income tax (expense) benefit | (50,768) | - | 70,799 | - | ||
| Net loss | $(14,306,704) | $(6,865,270) | $(25,425,276) | $(9,711,914) | ||
| Net loss per share, basic and diluted | $(0.64) | $(0.43) | $(1.15) | $(0.61) | ||
| Weighted average number of common shares outstanding, basic and diluted | 22,196,265 | 15,906,725 | 22,171,931 | 15,908,560 | ||
| Other comprehensive income (loss) | ||||||
| Net loss | $(14,306,704) | $(6,865,270) | $(25,425,276) | $(9,711,914) | ||
| Foreign currency translation | 110,000 | - | (4,881,144) | - | ||
| Change in pension benefit obligation | (33,406) | - | 121,272 | - | ||
| Total comprehensive loss | $(14,230,110) | $(6,865,270) | $(30,185,148) | $(9,711,914) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.